Advertisement
UK markets closed

  • FTSE 100

    7,895.85
    +18.80 (+0.24%)
     

  • FTSE 250

    19,391.30
    -59.37 (-0.31%)
     

  • AIM

    745.67
    +0.38 (+0.05%)
     

  • GBP/EUR

    1.1618
    -0.0065 (-0.56%)
     

  • GBP/USD

    1.2379
    -0.0059 (-0.47%)
     

  • Bitcoin GBP

    52,080.62
    +1,460.40 (+2.89%)
     

  • CMC Crypto 200

    1,383.84
    +71.22 (+5.42%)
     

  • S&P 500

    4,979.97
    -31.15 (-0.62%)
     

  • DOW

    37,974.95
    +199.57 (+0.53%)
     

  • CRUDE OIL

    83.30
    +0.57 (+0.69%)
     

  • GOLD FUTURES

    2,407.90
    +9.90 (+0.41%)
     

  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

  • HANG SENG

    16,224.14
    -161.73 (-0.99%)
     

  • DAX

    17,737.36
    -100.04 (-0.56%)
     

  • CAC 40

    8,022.41
    -0.85 (-0.01%)
     
Property:

11 beautiful homes with glorious garden rooms

Investing in a home with a garden room will enable you to enjoy your outside space whatever the weather

4 big analyst picks: Avis Budget zooms higher on Deutsche upgrade

Investing.com
·2-min read

By Davit Kirakosyan

Here is your Pro Recap of the biggest analyst picks you may have missed since yesterday: upgrades at Avis Budget, Q2, bluebird bio, Equitrans Midstream, and Financial Services.

InvestingPro subscribers got this news first. Never miss another market-moving headline.

Avis stock gains on Deutsche Bank’s upgrade

Avis Budget Group (NASDAQ:CAR) shares gained more than 2% yesterday after Deutsche Bank upgraded the company to Buy from Hold and raised its price target to $263.00 from $239.00, as InvestingPro reported in real time.

The firm mentioned that the stock has been "left behind without cause," and emphasized the upgrade's main focus on the company's valuation.

ADVERTISEMENT

Furthermore, the bank highlighted a potential catalyst in the form of expected share repurchases in the latter half of the year. Shares have significantly underperformed comparable travel and leisure sub-sectors year-to-date, lagging behind by an average of 2,400 basis points. The firm believes that the stock could attract investors looking to buy reasonably priced laggards as the S&P 500 sits near a 9-month high.

Q2 upgraded to Buy, shares surge 5%

Q2 (NYSE:QTWO) shares rose more than 5% yesterday after BTIG upgraded the company to Buy from Neutral with a price target of $36.00, highlighting its increasingly constructive view of the long-term outlook for the company.

The firm believes Q2’s guidance is now conservative and much of the potential downside has been stripped out, while growth upside is more tangible than in recent years.

2 more upgrades

Bluebird bio (NASDAQ:BLUE) shares jumped more than 6% premarket today after Barclays upgraded the company to Overweight from Equalweight and raised its price target to $8.00 from $7.00.

JPMorgan upgraded Intercorp Financial Services (NYSE:IFS) to Overweight from Neutral with a price target of $27.00.

Amid an endless firehose of market headlines, jump on the most important ones to fatten your profits: Always be the first to know with InvestingPro.

Start your free 7-day trial now.

Related Articles

4 big analyst picks: Avis Budget zooms higher on Deutsche upgrade

Nordstrom gains after topping Q1 estimates, but analysts remain bearish

Okta down 20% after earnings, analysts downgrade